Efficacy of laparoscopic myomectomy using transient uterine artery occlusion

Aim: to evaluate the clinical efficacy of laparoscopic myomectomy using transient uterine artery occlusion in reproductive age patients with symptomatic uterine fibroids.

Materials and Мethods. The prospective comparative study included 20 women randomly assigned to two groups: standard laparoscopic myomectomy (n = 10) and laparoscopic myomectomy with transient uterine arteries occlusion (n = 10). The duration of the operation, the volume of intraoperative blood loss, the dynamics of hemoglobin levels, the duration of hospitalization, and the frequency of complications were evaluated.

Results. Both groups were comparable in baseline clinical and demographic characteristics. In main group, there was a significant decrease in intraoperative blood loss (210.5 ± 195.4 ml vs. 365.2 ± 214.1 ml; p = 0.03), while the duration of surgery and the level of postoperative hemoglobin did not differ significantly. Most of the interventions were completed by laparoscopic access without conversion, and frequency of early complications was comparable in both groups.

Conclusion. Transient occlusion of the uterine arteries during laparoscopic myomectomy improves the safety of the intervention by reducing blood loss and does not increase the risk of complications. The practical significance implies that the use of this technology can contribute to safer operations and preserve patients’ reproductive health. Thus, positively contributes to improving current gynecological surgery.

1. Vikhlyaeva E.M. Manual on diagnosis and therapy of uterine leiomyoma. [Rukovodstvo po diagnostike i lecheniyu lejomiomy matki]. Moscow: MEDpress-inform, 2004. 399 p. (In Russ.).

2. Andreeva Yu.E., Vtorenko V.I., Dymkovets V.P. et al. Laparoscopic organsparing surgery in the treatment of patients with uterine myoma. [Laparoskopicheskaya organosohranyayushchaya hirurgiya v lechenii bol'nyh s miomoj matki]. Rossijskij vestnik akushera-ginekologa. 2016;16(6):73–6. (In Russ.). https://doi.org/10.17116/rosakush201616673-76.

3. Shvarev E.G., Dikareva L.V., Ayupova A.K. et al. Structural and biochemical features of menstrual discharge in patients with uterine fibroids. [Strukturnye i biohimicheskie osobennosti menstrual'nyh vydelenij u bol'nyh s miomoj matki]. Rossijskij vestnik akushera-ginekologa. 2024;24(6):85–90. https://doi.org/10.17116/rosakush20242406185. (In Russ.).

4. Shchukina N.A., Kareva E.N., Kochetkova A.A. et al. Controversial issues of adjuvant therapy after myomectomy. [Diskussionnye voprosy ad"yuvantnoj terapii posle miomektomii]. Rossijskij vestnik akusheraginekologa. 2024;24(5):101–7. (In Russ.). https://doi.org/10.17116/rosakush202424051101.

5. Buryak M.M., Aganezov S.S., Aganezova N.V. Characteristics of menstrual function and laboratory parameters of blood tests in women with uterine fibroids using three-phase and monophasic combined hormonal contraceptives. [Harakteristiki menstrual'noj funkcii i laboratornye pokazateli analizov krovi u zhenshchin s miomoj matki pri ispol'zovanii trekhfaznyh i monofaznyh kombinirovannyh gormonal'nyh kontraceptivov]. Zhurnal akusherstva i zhenskih boleznej. 2025;74(1):26– 39. (In Russ.). https://doi.org/10.17816/JOWD636656.

6. Atanesyan E.G., Penzhoian G.A., Andreeva M.D., Khachak SN. Clinical observation of precautious preparation and delivery outcome in a patient with recurrent endometrial pathology against the background of chronic endometritis of viral etiology. [Klinicheskoe nablyudenie pregravidarnoj podgotovki i iskhoda rodov u pacientki s recidiviruyushchej patologiej endometriya na fone hronicheskogo endometrita virusnoj etiologii]. Rossijskij vestnik akushera-ginekologa. 2019;19(6):65–8. (In Russ.). https://doi.org/10.17116/rosakush20191906165.

7. Moratalla-Bartolomé E., Lázaro-de-la-Fuente J., López-Carrasco I. et al. Surgical impact of bilateral transient occlusion of uterine and uteroovarian arteries during laparoscopic myomectomy. Sci Rep. 2024;14(1):7044. https://doi.org/10.1038/s41598-024-57720-9.

8. Peng Y., Cheng J., Zang C. et al. Comparison of laparoscopic myomectomy with and without uterine artery occlusion in treatment of symptomatic multiple myomas. Int J Gen Med. 2021;14:1719–25. https://doi.org/10.2147/IJGM.S310864.

9. Barbosa P.A., Villaescusa M., Andres M.P. et al. How to minimize bleeding in laparoscopic myomectomy. Curr Opin Obstet Gynecol. 2021;33(4):255– 61. https://doi.org/10.1097/GCO.0000000000000725.

10. Giuliani E., As-Sanie S., Marsh E.E. Epidemiology and management of uterine fibroids. Int J Gynaecol Obstet. 2020;149(1):3–9. https://doi.org/10.1002/ijgo.13102.

11. Kim T., Purdy M.P., Kendall-Rauchfuss L. et al. Myomectomy associated blood transfusion risk and morbidity after surgery. Fertil Steril. 2020;114(1):175–84. https://doi.org/10.1016/j.fertnstert.2020.02.110.

12. Dumitrașcu M.C., Nenciu C.G., Nenciu A.E. et al. Laparoscopic myomectomy – the importance of surgical techniques. Front Med (Lausanne) 2023;10:1158264. https://doi.org/10.3389/fmed.2023.1158264. Erratum in: Front Med (Lausanne). 2023;10:1251421. https://doi.org/10.3389/fmed.2023.1251421.

13. Baradwan S., Hafedh B., Himayda S. et al. The impact of bilateral transient occlusion of uterine and utero-ovarian arteries on surgical blood loss during laparoscopic myomectomy: A systematic review and meta-analysis of randomized controlled trials. Eur J Obstet Gynecol Reprod Biol. 2025;305:241–7. https://doi.org/10.1016/j.ejogrb.2024.12.033.

14. Streuli I., Ramyead L., Silvestrini N. et al. Impact of definitive uterine artery occlusion on ovarian reserve markers in laparoscopic myomectomy: a randomized controlled trial with 2-year follow-up. Hum Reprod. 2025;40(7):1305–14. https://doi.org/10.1093/humrep/deaf070.

15. Sanders A.P., Norris S., Tulandi T., Murji A. Reproductive outcomes following uterine artery occlusion at the time of myomectomy: systematic review and meta-analysis. J Obstet Gynaecol Can. 2020;42(6):787–97.e2. https://doi.org/10.1016/j.jogc.2019.06.011.

16. De La Cruz M.S., Buchanan E.M. Uterine fibroids: diagnosis and treatment. Am Fam Physician. 2017;95(2):100–7.

17. Stewart E.A., Cookson C.L., Gandolfo R.A., Schulze-Rath R. Epidemiology of uterine fibroids: a systematic review. BJOG. 2017;124(10):1501-12. https://doi.org/10.1111/1471-0528.14640.

18. Pritts E.A., Parker W.H., Olive D.L. Fibroids and infertility: an updated systematic review of the evidence. Fertil Steril. 2009;91(4):1215–23.